How Caitlyn Krebs Built an AI Engine That Designs Drugs 5x Faster

Episode notes

In this episode of Pharma Sessions, host Jonathan Kaskey is joined by Caitlyn Krebs, Co-Founder and CEO of Nalu Bio, to share insights about AI-driven drug development, specifically targeting the endocannabinoid system (ECS) for therapeutic development in pain management, inflammation, and women’s health. Pharma Sessions is hosted by Jonathan Kaskey

• The Question Behind the Question - Field Training with Jennifer Muszik47 / 100
• Why the Small Details Reveal Everything About Your CDMO Partner with Frank Sorce46 / 100
• Why Medical Knowledge Isn’t Reaching Patients with Dr. Simon Chowdhury49 / 100
• Timothy Smith on AI, Data, and Drug Discovery at Takeda
• Lessons on Leading Through Uncertainty in Pharma